Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Applied DNA Sciences Inc APDN

Technology Scientific & Technical Instruments
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic... see more

Recent & Breaking News (NDAQ:APDN)

Applied DNA Announces Receipt of International Patents on its Beacon® Secure Optical Molecular Marker Technologies

Business Wire February 24, 2020

Applied DNA Receives Kosher Certification from Orthodox Union for Qualifying Products

Business Wire February 20, 2020

Applied DNA Enters Dietary Supplements Market with Multi-Year Nutrition21 Contract

Business Wire February 19, 2020

Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV

Business Wire February 7, 2020

Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT® Platform in Man-Made Cellulosic Fibers and Materials

Business Wire February 7, 2020

Applied DNA Reports 2020 Fiscal First Quarter Financial Results

Business Wire February 6, 2020

Applied DNA Schedules Fiscal 2020 First Quarter Financial Results Conference Call for Thursday, February 6, 2020 at 4:30 PM ET

Business Wire January 30, 2020

Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT® Platform in Man-Made Cellulosic Fibers and Materials

Business Wire January 27, 2020

Applied DNA Subsidiary, LineaRx, Inc., Signs Licensing Agreement with LifeSensors, Inc.

Business Wire January 13, 2020

Applied DNA to Hold Investment Community Meetings During the JP Morgan 38th Annual Healthcare Conference and Present at the Biotech Showcase 2020

Business Wire January 10, 2020

Colorcon, Inc. Launches On-Dose Authentication Platform From Applied DNA Sciences

Business Wire December 23, 2019

Applied DNA Reports 2019 Year End and Fiscal Fourth Quarter Financial Results

Business Wire December 12, 2019

Applied DNA and Old Port Oil to Conduct First Pilot to Tag CBD Oil

Business Wire December 11, 2019

Applied DNA Sciences and Reliance Industries Sign MOU to Incorporate CertainT Forensic Traceability Into R|Elan Fabric and Recron GreenGold® Recycled Polyester Fiber and Filament

Business Wire December 10, 2019

Applied DNA Schedules Fiscal 2019 Fourth Quarter Financial Results Conference Call for Thursday, December 12, 2019 at 4:30 PM ET

Business Wire December 5, 2019

Applied DNA Sciences Subsidiary LineaRx Signs Agreement with TYME Technologies for Functional Invasive Circulating Tumor Cell Assay Services in Pancreatic Cancer Trial

Business Wire November 26, 2019

Applied DNA Sciences Regains Compliance with Nasdaq Listing Standards

Business Wire November 25, 2019

Applied DNA Sciences Reports 14 Development Customers for its Linear DNA Manufacturing Platform

Business Wire November 25, 2019

Applied DNA Sciences Announces Closing of Upsized $12.0 Million Underwritten Public Offering

Business Wire November 15, 2019

Applied DNA Sciences Announces Pricing of Upsized $12.0 Million Underwritten Public Offering

Business Wire November 13, 2019